ISSN (print) 1997-6933     ISSN (online) 2500-2139
Vol. 16 No. 2 (2023), BONE MARROW TRANSPLANTATION
Vol. 16 No. 2 (2023)
BONE MARROW TRANSPLANTATION

T-Helper Subpopulations in Acute Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation

Published 20.02.2024
Yuliya Olegovna Davydova
National Research Center for Hematology, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167
N.M. Kapranov
National Research Center for Hematology, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167
K.A. Nikiforova
National Research Center for Hematology, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167
O.S. Karavaeva
National Research Center for Hematology, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167
D.V. Kamelskikh
National Research Center for Hematology, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167
M.Yu. Drokov
National Research Center for Hematology, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167
L.A. Kuzmina
National Research Center for Hematology, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167
T.V. Gaponova
National Research Center for Hematology, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167
I.V. Galtseva
National Research Center for Hematology, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167
E.N. Parovichnikova
National Research Center for Hematology, 4 Novyi Zykovskii pr-d, Moscow, Russian Federation, 125167
2023-2
PDF_2023-16-2_137-145 (Russian)

Keywords

flow cytometry
Т-cells
Т-helpers
blood donors
lymphocyte subpopulations

How to Cite

Davydova Y.O., Kapranov N.M., Nikiforova K.A., Karavaeva O.S., Kamelskikh D.V., Drokov M.Y., Kuzmina L.A., Gaponova T.V., Galtseva I.V., Parovichnikova E.N. T-Helper Subpopulations in Acute Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation. Clinical Oncohematology. 2024;(2):137–145. doi:10.21320/2500-2139-2023-16-2-137-145.
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver AMA ГОСТ

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Keywords

Abstract

Aim. To identify the characteristics of T-helper subpopulations in healthy donors and to compare them with those reported in acute leukemia patients 6 months after allogeneic hematopoietic stem cell transplantation (allo-HSCT).

Materials & Methods. The study enrolled 41 blood donors and 49 patients after-HSCT. The median age of donors was 36 years (range 20–60 years), 29 of them were men and 12 were women. The median age of patients was 37 years (range 19–62 years), 18 of them were men and 31 were women. Acute myeloid leukemia was diagnosed in 27 (55 %) patients and acute lymphoblastic leukemia/lymphoma in 22 (45 %) patients. Myeloablative conditioning was administered to 4 (8 %) patients and reduced intensity conditioning to 45 (92 %) patients. T-helper subpopulations were studied in the blood of healthy donors vs. acute leukemia patients after allo-HSCT. The flow cytometry analysis was conducted to simultaneously assess the expression of markers CD3, CD4, CD8, CD25, CD45RA, CD197, CD28, CCR4, CCR6, CCR10, CXCR3, and CXCR5 in T-cells.

Results. The study demonstrated that the count of T-helpers at different stages of differentiation (regulatory, naive T-cells, memory cells, and effector cells) comprehensively distinguishes healthy donors from patients. Moreover, the functional structure of each of these populations differ in donors vs. patients even on Month +6 after allo-HSCT. Donors appeared to have more polarized cells among the central memory T-helpers. The proportion of T-helpers type 1 among the effector cells was higher is patients.

Conclusion. The results of the study indicate that the Т-cell parameter set can be analyzed to assess immunity and to describe its disorders in different pathologies or after drug chemotherapy.

PDF_2023-16-2_137-145 (Russian)

References

  1. Lugli E, Pinti M, Nasi M, et al. Subject classification obtained by cluster analysis and principal component analysis applied to flow cytometric data. Cytom Part A. 2007;71(5):334–44. doi: 10.1002/CYTO.A.20387.
  2. Shevyrev D, Tereshchenko V. Treg Heterogeneity, Function, and Homeostasis. Front Immunol. 2020;10:3100. doi: 10.3389/FIMMU.2019.03100/BIBTEX.
  3. Mahnke YD, Brodie TM, Sallusto F, et al. The who’s who of T-cell differentiation: Human memory T-cell subsets. Eur J Immunol. 2013;43(11):2797–809. doi: 10.1002/eji.201343751.
  4. Hammarlund E, Lewis MW, Hansen SG, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med. 2003;9(9):1131–7. doi: 10.1038/NM917.
  5. Dawes R, Petrova S, Liu Z, et al. Combinations of CD45 Isoforms Are Crucial for Immune Function and Disease. J Immunol. 2006;176(6):3417. doi: 10.4049/JIMMUNOL.176.6.3417.
  6. Gattinoni L, Lugli E, Ji Y, et al. A human memory T-cell subset with stem cell-like properties. Nat Med. 2011;17(10):1290. doi: 10.1038/NM.2446.
  7. Lugli E, Dominguez MH, Gattinoni L, et al. Superior T memory stem cell persistence supports long-lived T cell memory. J Clin Invest. 2013;123(2):594. doi: 10.1172/JCI66327.
  8. Romero P, Zippelius A, Kurth I, et al. Four Functionally Distinct Populations of Human Effector-Memory CD8+ T Lymphocytes. J Immunol. 2007;178(7):4112–9. doi: 10.4049/JIMMUNOL.178.7.4112.
  9. Bonecchi R, Bianchi G, Bordignon PP, et al. Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s. J Exp Med. 1998;187(1):129–34. doi: 10.1084/JEM.187.1.129.
  10. Duhen T, Geiger R, Jarrossay D, et al. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol. 2009;10(8):857–63. doi: 10.1038/ni.1767.
  11. Rivino L, Messi M, Jarrossay D, et al. Chemokine Receptor Expression Identifies Pre–T Helper (Th)1, Pre–Th2, and Nonpolarized Cells among Human CD4+ Central Memory T Cells. J Exp Med. 2004;200(6):725–35. doi: 10.1084/JEM.20040774.
  12. Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells. Nat Immunol. 2007;8(6):639–46. doi: 10.1038/ni1467.
  13. Zhang N, Pan HF, Ye DQ. Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol Cell Biochem. 2011;353(1):41–6. doi: 10.1007/S11010-011-0772-Y.
  14. Bunjun R, Omondi FMA, Makatsa MS, et al. Th22 Cells Are a Major Contributor to the Mycobacterial CD4+ T Cell Response and Are Depleted During HIV Infection. J Immunol. 2021;207(5):1239–49. doi: 10.4049/JIMMUNOL.1900984.
  15. Beilhack A, Schulz S, Baker J, et al. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood. 2005;106(3):1113–22. doi: 10.1182/blood-2005-02-0509.
  16. Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, Serody JS. Leukocyte migration and graft-versus-host disease. Blood. 2005;105(11):4191–9. doi: 10.1182/blood-2004-12-4726.
  17. Попова Н.Н, Савченко В.Г. Реконституция Т-клеточного звена иммунной системы у больных после трансплантации аллогенных гемопоэтических стволовых клеток. Гематология и трансфузиология. 2020;65(1):24–38. doi: 10.35754/0234-5730-2020-65-1-24-38.
  18. [Popova NN, Savchenko VG. Reconstitution of T-cell-mediated immunity in patients after allogeneic stem cell transplantation. Russian journal of hematology and transfusiology. 2020;65(1):24–38. doi: 10.35754/0234-5730-2020-65-1-24-38. (In Russ)]
  19. Ringhoffer S, Rojewski M, Dohner H, et al. T-cell reconstitution after allogeneic stem cell transplantation: assessment by measurement of the sjTREC/βTREC ratio and thymic naive T cells. Haematologica. 2013;98(10):1600–8. doi: 10.3324/haematol.2012.072264.
  20. Pei X, Zhao X, Wang Y, et al. Comparison of reference values for immune recovery between event-free patients receiving haploidentical allografts and those receiving human leukocyte antigen-matched sibling donor allografts. Front Med. 2017;12(2):153–63. doi: 10.1007/S11684-017-0548-1.
  21. Благов С.Л., Шелихова Л.Н., Осипова Е.Ю. и др. Применение инфузий T-клеток памяти с целью профилактики вирусных инфекций у пациентов с гемобластозами, перенесших аллогенную трансплантацию гемопоэтических стволовых клеток с деплецией альфа/бета Т-лимфоцитов. Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2018;17(2):9–20.
  22. [Blagov SL, Shelikhova LN, Osipova EYu, et al. Low dose donor memory T-cell infusion after TCR alpha/beta depleted stem cell transplantation for patients with malignant disorders. Voprosy gematologii/onkologii i immunopatologii v pediatrii. 2018;17(2):9–20. (In Russ)]
  23. Mahnke YD, Beddall MH, Roederer M. OMIP-017: Human CD4+ Helper T-cell Subsets Including Follicular Helper Cells. Cytometry A. 2013;83(5):439. doi: 10.1002/CYTO.A.22269.
  24. Spadea M, Saglio F, Tripodi SI, et al. Multivariate Analysis of Immune Reconstitution and Relapse Risk Scoring in Children Receiving Allogeneic Stem Cell Transplantation for Acute Leukemias. Transplant Direct. 2021;7(11):e774. doi: 10.1097/TXD.0000000000001226.
  25. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med. 1995;332(3):143–9. doi: 10.1056/NEJM199501193320303.
  26. Hakim FT, Memon SA, Cepeda R, et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest. 2005;115(4):930–9. doi: 10.1172/JCI22492.
  27. Van Den Brink MRM, Velardi E, Perales MA. Immune reconstitution following stem cell transplantation. Hematol Am Soc Hematol Educ Progr. 2015;2015(1):215–9. doi: 10.1182/asheducation-2015.1.215.
  28. Dean HF, Cazaly A, Hurlock C, et al. Defects in lymphocyte subsets and serological memory persist a median of 10 years after high-dose therapy and autologous progenitor cell rescue for malignant lymphoma. Bone Marrow Transplant. 2012;47(12):1545–51. doi: 10.1038/bmt.2012.73.
  29. Chung B, Barbara-Burnham L, Barsky L, Weinberg K. Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation. Blood. 2001;98(5):1601–6. doi: 10.1182/blood.V98.5.1601.
  30. Mackall CL, Fleisher TA, Brown MR, et al. Distinctions Between CD8+ and CD4+ T-Cell Regenerative Pathways Result in Prolonged T-Cell Subset Imbalance After Intensive Chemotherapy. Blood. 1997;89(10):3700–7. doi: 10.1182/blood.V89.10.3700.
  31. Poulin JF, Sylvestre M, Champagne P, et al. Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease. Blood. 2003;102(13):4600–7. doi: 10.1182/blood-2003-05-1428.
  32. Wang YT, Kong Y, Song Y, et al. Increased Type 1 Immune Response in the Bone Marrow Immune Microenvironment of Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016;22(8):1376–82. doi: 10.1016/J.BBMT.2016.04.016.
  33. Monteiro JP, Bonomo A. Linking immunity and hematopoiesis by bone marrow T cell activity. Brazilian J Med Biol Res. 2005;38(10):1475–86. doi: 10.1590/S0100-879X2005001000004.
  34. Monteiro JP, Benjamin A, Costa ES, et al. Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells. Blood. 2005;105(4):1484–91. doi: 10.1182/blood-2004-07-2856.
  35. Bonomo A, Monteiro AC, Goncalves-Silva T, et al. A T cell view of the bone marrow. Front Immunol. 2016;7:184. doi: 10.3389/FIMMU.2016.00184/BIBTEX.
  36. Yang YG, Dey BR, Sergio JJ, et al. Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12. J Clin Invest. 1998;102(12):2126–35. doi: 10.1172/JCI4992.
  37. Engelhardt BG, Paczesny S, Jung DK, et al. Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation. Haematologica. 2016;101(5):e204–e208. doi: 10.3324/haematol.2015.139501.
  38. Brok HPM, Vossen JM, Heidt PJ. Interferon-γ-mediated prevention of graft-versus-host disease: Development of immune competent and allo-tolerant T cells in chimeric mice. Bone Marrow Transplant. 1997;19(6):601–6. doi: 10.1038/SJ.BMT.1700707.
  39. Carlson MJ, West ML, Coghill JM, et al. In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood. 2009;113(6):1365–74. doi: 10.1182/blood-2008-06-162420.
  40. Crane IJ, Forrester JV. Th1 and Th2 Lymphocytes in Autoimmune Disease. Crit Rev Immunol. 2005;25(2):75–102. doi: 10.1615/critrevimmunol.V25.I2.10.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.